Emerging Trends in Opioid Use Disorder Management: A 6-Year Analysis of Emergency Department Visits, Buprenorphine Prescriptions, and Naloxone Distribution (2016–2021)

Abid Rizvi, MD; Deep Yadava, MD; Christina L. Nolte, MSPA-C; Paramjit Chumber, MD; Issaiah Wallace, DNP, APRN, PMHNP-BC; Amit Jagtiani, MD

Prim Care Companion CNS Disord 2024;26(2):23br03659

Free Access: Please Log In

This content is completely free—but you need to be logged in to read the full article. If you already have an account, please log in below. Otherwise, register for free to unlock instant access.

References (30)

Spencer MR, Miniño AM, Warner M. Drug overdose deaths in the United States, 2001–2021. NCHS Data Brief. 2022;(457):1–8. PubMed CrossRef
Drug overdose death rates. National Institutes of Health. Updated June 30, 2023. Accessed September 10, 2023. https://nida.nih.gov/research-topics/trends-statistics/overdose-death-rates
Gomes T, Tadrous M, Mamdani MM, et al. The burden of opioid-related mortality in the United States. JAMA Netw Open. 2018;1(2):e180217. PubMed CrossRef
Weiner SG, Baker O, Bernson D, et al. One-year mortality of patients after emergency department treatment for nonfatal opioid overdose. Ann Emerg Med. 2020;75(1):13–17. PubMed CrossRef
D’Onofrio G, O’Connor PG, Pantalon MV, et al. Emergency department-initiated buprenorphine/naloxone treatment for opioid dependence: a randomized clinical trial. JAMA. 2015;313(16):1636–1644. PubMed CrossRef
Initiating buprenorphine treatment in the emergency department. National Institutes of Health. Updated March 17, 2023. Accessed September 10, 2023. https://nida.nih.gov/nidamed-medical-health-professionals/discipline-specific-resources/emergency-physicians-first-responders/initiating-buprenorphine-treatment-in-emergency-department
Herring AA, Vosooghi AA, Luftig J, et al. High-dose buprenorphine induction in the emergency department for treatment of opioid use disorder. JAMA Netw Open. 2021;4(7):e2117128. PubMed CrossRef
Bitterman RA. EMTALA and the ethical delivery of hospital emergency services. Emerg Med Clin North Am. 2006;24(3):557–577. PubMed CrossRef
Carroll C, Hand D, Covington W, et al. Emergency-department initiated buprenorphine: impact on quality of life. Drug Alcohol Depend Rep. 2023;9:100191. PubMed CrossRef
Key substance use and mental health indicators in the United States: results from the 2017 National Survey on Drug Use and Health (HHS Publication No. SMA 18-5068, NSDUH Series H-53). Substance Abuse and Mental Health Services Administration. Accessed September 10, 2023. https://www.samhsa.gov/data/sites/default/files/cbhsq-reports/NSDUHFFR2017/NSDUHFFR2017.pdf
Rhee TG, D’Onofrio G, Fiellin DA. Trends in the use of buprenorphine in US emergency departments, 2002–2017. JAMA Netw Open. 2020;3(10):e2021209. PubMed CrossRef
National Hospital Ambulatory Medical Care Survey (NHAMCS). Centers for Disease Control and Prevention. Accessed September 15, 2023. https://ftp.cdc.gov/pub/Health_Statistics/NCHS/dataset_documentation/nhamcs/spss/
Vandenbroucke JP, von Elm E, Altman DG, et al. Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. Ann Intern Med. 2007;147(8):W163–W194. PubMed CrossRef
Venkatesh AK, Janke AT, Kinsman J, et al. Emergency department utilization for substance use disorders and mental health conditions during COVID-19. PLoS One. 2022;17(1):e0262136. PubMed CrossRef
Clinical Classifications Software Refined (CCSR) for ICD-10-CM diagnoses. Healthcare Cost & Utilization Project. Accessed September 15, 2023. https://hcup-us.ahrq.gov/toolssoftware/ccsr/dxccsr.jsp#download
Opioid facts. U.S. Department of Justice. Updated November 28, 2022. Accessed September 10, 2023. https://www.justice.gov/opioidawareness/opioid-facts
Drug overdose deaths in the U.S. top 100,000 annually. Centers for Disease Control and Prevention. Updated November 17, 2021. Accessed September 10, 2023. https://www.cdc.gov/nchs/pressroom/nchs_press_releases/2021/20211117.htm
Soares WE 3rd, Melnick ER, Nath B, et al. Emergency department visits for nonfatal opioid overdose during the COVID-19 pandemic across six US health care systems. Ann Emerg Med. 2022;79(2):158–167. PubMed CrossRef
Wu LT, Zhu H, Swartz MS. Treatment utilization among persons with opioid use disorder in the United States. Drug Alcohol Depend. 2016;169:117–127. PubMed CrossRef
Mojtabai R, Mauro C, Wall MM, et al. Medication treatment for opioid use disorders in substance use treatment facilities. Health Aff (Millwood). 2019;38(1):14–23. PubMed CrossRef
Guo CZ, D’Onofrio G, Fiellin DA, et al. Emergency department-initiated buprenorphine protocols: a national evaluation. J Am Coll Emerg Physicians Open. 2021;2(6):e12606. PubMed CrossRef
Schackman BR, Leff JA, Polsky D, et al. Cost-effectiveness of long-term outpatient buprenorphine-naloxone treatment for opioid dependence in primary care. J Gen Intern Med. 2012;27(6):669–676. PubMed CrossRef
Thomas CP, Fullerton CA, Kim M, et al. Medication-assisted treatment with buprenorphine: assessing the evidence. Psychiatr Serv. 2014;65(2):158–170. PubMed CrossRef
Volkow ND, Frieden TR, Hyde PS, et al. Medication-assisted therapies—tackling the opioid-overdose epidemic. N Engl J Med. 2014;370(22):2063–2066. PubMed CrossRef
Thomas CP, Stewart MT, Tschampl C, et al. Emergency department interventions for opioid use disorder: a synthesis of emerging models. J Subst Abuse Treat. 2022;141:108837. PubMed CrossRef
D’Onofrio G, McCormack RP, Hawk K. Emergency departments – a 24/7/365 option for combating the opioid crisis. N Engl J Med. 2018;379(26): 2487–2490. PubMed CrossRef
Devries J, Rafie S, Ajayi TA, et al. Results of a naloxone screening quality-improvement project in an academic emergency department. J Emerg Med. 2019;56(4):378–385. PubMed CrossRef
Kestler A, Buxton J, Meckling G, et al. Factors associated with participation in an emergency department-based take-home naloxone program for at-risk opioid users. Ann Emerg Med. 2017;69(3):340–346. PubMed CrossRef
Gunn AH, Smothers ZPW, Schramm-Sapyta N, et al. The emergency department as an opportunity for naloxone distribution. West J Emerg Med. 2018;19(6):1036–1042. PubMed CrossRef
O’Brien DC, Dabbs D, Dong K, et al. Patient characteristics associated with being offered take home naloxone in a busy, urban emergency department: a retrospective chart review. BMC Health Serv Res. 2019;19(1):632. PubMed CrossRef